AUC	Area under the curve
Cl	Clearance
Cmax	peak plasma concentration
DAPI	4′,6-diamidino-2-phenylindole
E.E.	encapsulation efficiency
Fr	relative oral bioavailability
FRA	fraction of resveratrol absorbed
FRD	fraction of resveratrol released
IVIVC	In vitro-in vivo correlations
LR-NP	Lumogen red-loaded casein nanoparticles
MRT	mean residence time
NP-C	empty casein nanoparticles
NP-NOTA-Ga	casein nanoparticles radiolabeled with Gallium-67
PCS	photon correlation spectroscopy
PDI	polydispersity index
PEG	polyethylene glycol 400
Rsv	resveratrol
Rsv-IV	resveratrol solution intravenously administered
Rsv-NP-C	resveratrol-loaded casein nanoparticles
Rsv-Sol	solution of resveratrol in a mixture of PEG 400 and water
Rsv-Susp	aqueous suspension of resveratrol
SGF	simulated gastric fluid
SIF	simulated intestinal fluid
t1/2	half-life of the terminal phase
Tmax	time to reach plasma concentration